Today the US Food and Drug Administration is announcing that it has approved Xofigo to treat men with symptomatic late-stage, castration-resistant prostate cancer that has spread to bones but not to other organs.
http://www.cancertreatment.net/news/prostate-cancer/fda-approves-new-prostate-cancer-drug
http://www.cancertreatment.net/news/prostate-cancer/fda-approves-new-prostate-cancer-drug
No comments:
Post a Comment